Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Clinical trial NCT02432274 · COMPLETED

Trial details

NCT number: NCT02432274
Sponsor: Eisai Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tumors Solid Malignant Tumors Osteosarcoma Differentiated Thyroid Cancer (DTC)

Start date: 2014-12-29
Primary completion: 2019-07-18
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.